During my undergraduate studies in microbiology, I developed a deep interest in vaccinology as I grappled with the complexities of creating vaccines that are both safe and potent in combating infectious diseases. With a Master's and a PhD in preventive veterinary medicine, I have established a robust expertise in formulating vaccines for veterinary diseases. My passion for this field was further cultivated during my PhD as a researcher in Professor Lee John Hwa's laboratory at the College of Veterinary Medicine, Jeonbuk National University in South Korea, where I specialized in developing vaccine platforms. During my postgraduate studies, I have authored 8 research articles as the first author and contributed to 31 co-authored research articles. I have also presented numerous posters and oral presentations at international Microbiology, Immunology, and Biomedical conferences from 2017 to 2023. My work has garnered 360 citations on Google Scholar and maintains a H-index of 9. My expertise spans over seven years and encompasses molecular cloning, expression profiling in both prokaryotic and eukaryotic cells, cell culture (involving primary cell isolation and culture, as well as eukaryotic cell lines), development of cancer models, immunoblotting, E. coli expression system for recombinant protein purification, immunofluorescence assay, ELISA, and Lambda red recombination technique. Additionally, I have extensive experience in conducting in-vivo and in-vitro experiments with BSL2 and BSL3 laboratory-level viruses and bacteria, such as SARS-CoV2, SFTSV, Influenza, PEDV, IBV, Brucella, and others. Currently, I am working as a research scientist at the Sri Lanka Institute of Biotechnology (SLIBTEC) and embarking on developing an inactivated rabies vaccine, which is anticipated to benefit the veterinary sector and contribute significantly to the country's overall economic growth. My primary focus is to detect zoonotic diseases of major concern and analyze the existing approaches and obstacles in creating vaccines for these animal diseases. Additionally, I intend to delve into the concepts of customizing vaccine platforms for particular animal diseases and assess the potential influence of these specialized vaccine platforms on public health.